Ruggenenti P, et al.. Preventing microalbuminuria in type 2 diabetes. N Engl J Med 2004; 351:1941–1951.

• PubMed
Ruggenenti P, . Preventing microalbuminuria in type 2 diabetes. N Engl J Med 2004; 351:1941–1951.)| false
• Search Google Scholar
• Export Citation

Yusuf S, et al.. Effects of an angiotensin-converting–enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342:145–153.

• PubMed
Yusuf S, . Effects of an angiotensin-converting–enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342:145–153.)| false
• Search Google Scholar
• Export Citation

de Zeeuw D, et al.. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease for the BEACON trial investigators. N Engl J Med 2013; 369:2492–2503.

• PubMed
de Zeeuw D, . Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease for the BEACON trial investigators. N Engl J Med 2013; 369:2492–2503.)| false
• Search Google Scholar
• Export Citation

Menne J, et al.. C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria. Nephrol Dial Transplant 2017; 32:307–315.

• PubMed
Menne J, . C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria. Nephrol Dial Transplant 2017; 32:307–315.)| false
• Search Google Scholar
• Export Citation

Wanner C, et al.. Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med 2016; 375:323–334.

• PubMed
Wanner C, . Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med 2016; 375:323–334.)| false
• Search Google Scholar
• Export Citation

Zinman B, et al.. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 2015; 373:2117–2128.

• PubMed
Zinman B, . Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 2015; 373:2117–2128.)| false
• Search Google Scholar
• Export Citation

Perkovic V, et al.. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy [published online ahead of print Apr 14, 2019]. N Engl J Med doi:10.1056/NEJMoa1811744.

• PubMed
Perkovic V, . Canagliflozin and renal outcomes in type 2 diabetes and nephropathy [published online ahead of print Apr 14, 2019]. N Engl J Med doi:10.1056/NEJMoa1811744.)| false
• Search Google Scholar
• Export Citation

Groop P-H, et al.. Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: The randomized MARLINA-T2D trial. Diabetes, Obes Metab 2017; 19:1610–1619.

• PubMed
Groop P-H, . Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: The randomized MARLINA-T2D trial. Diabetes, Obes Metab 2017; 19:1610–1619.)| false
• Search Google Scholar
• Export Citation

Mann JFE, et al.. Liraglutide and renal outcomes in type 2 diabetes. N Engl J Med 2017; 377:839–848.

• PubMed
Mann JFE, . Liraglutide and renal outcomes in type 2 diabetes. N Engl J Med 2017; 377:839–848.)| false
• Search Google Scholar
• Export Citation

Van JAD, et al.. Insights into diabetic kidney disease using urinary proteomics and bioinformatics. J Am Soc Nephrol 2017; 28:1050–1061.

• PubMed
Van JAD, . Insights into diabetic kidney disease using urinary proteomics and bioinformatics. J Am Soc Nephrol 2017; 28:1050–1061.)| false
• Search Google Scholar
• Export Citation

Darshi M, et al.. Metabolomics in diabetic kidney disease: Unraveling the biochemistry of a silent killer. Am J Nephrol 2016; 44:92–103.

• PubMed
Darshi M, . Metabolomics in diabetic kidney disease: Unraveling the biochemistry of a silent killer. Am J Nephrol 2016; 44:92–103.)| false
• Search Google Scholar
• Export Citation

Verma S, McMurray JJV. SGLT2 inhibitors and mechanisms of cardiovascular benefit: A state-of-the-art review. Diabetologia 2018; 61:2108–2117.

• PubMed
Verma S, McMurray JJV. SGLT2 inhibitors and mechanisms of cardiovascular benefit: A state-of-the-art review. Diabetologia 2018; 61:2108–2117.)| false
• Search Google Scholar
• Export Citation